You have upped the ante for the Grosvenor House Hotel by taking the bid to pound 550 million. Is there room for further hike?
No we are not going to get in a bidding war. The amount we have pegged is based on the debt and operational ability of the hotel. This is fair valuation that that we have come up with. For some of the parties that have shown interest, they can increase their bid as it would just be a few hundred million dollar, but from a business point of view it does not make sense.
Would you look at partnering with any financial partner like PE for the same for funding?
We did say that it will be all cash deal but it will be a mix of debt and equity. The ratio could be 65:35 of equity and debt. We would not like to go with a third party financial player like PEs as they would have other conditions as well. If we were to look into the other two properties—The Plaza and Dream Downtown hotels in New York-- then we may have looked for a financial partner. But in this property we would not want any other financial partner.
Has Sahara responded to your bid?
Not so far. I doubt if Sahara is serious about selling these properties, as so far they have not yet got back to any of the bidders.
You also have plans to get Ritz Carlton, is hospitality big bet for you?
For us UK is special. Our family visits London atleast twice a month and I personally have lived there for years so we are familiar with that country and hence the interest. We have always maintained that we will buy only the Grosvenor House Hotel.
Yes we are bringing Ritz Carlton into Pune along with Panchshil Realty. Because we think there is a demand for such service in the area (the property is coming near Airport Road). But this does not mean we are getting into hospitality sector. What attracted us to Grosvenor is its unique size and location. It’s like a trophy asset. I would only look at UK if buying overseas.
What would be the area for expansion for the family business?
We would still focus on our core pharma business and the bio-tech industry. We have also looked at acquisition, like we acquire Netherlands-based Bilthoven Biologicals for Rs 550 crore (Rs 5.5 billion). We did have investment in Orchid Chemicals but that did not go well. We tried to diversify, but have had bad experience.
We are also interested in the real-estate sector. We have been buying and accumulating land. We are coming up with two townships—one near the Pune-Mumbai Highway and at Manjari.
Subrata Roy denied bail, allowed to meet clients outside jail
With bagful of admiration for Modi, John Kerry to arrive in India today
CWG PHOTOS: Glamorous athlete of the Day!
Chopper scam: Italy shelves case against Finmeccannica